Evicita · Supplement evidence, graded and cited · Supplements · Lifestyle · Mechanisms · Lab tests · 中文

Epigenetic inhibition of histone deacetylases (HDACs)

HDAC Inhibition & Chromatin Remodeling · Epigenetics and one-carbon methylation

Inhibits Class I/II HDAC enzyme activity, preserving acetyl groups on histone lysines. This relaxes compacted chromatin and reawakens protective genes that had been pathologically silenced.

Why it matters: A natural epigenetic reprogramming mechanism with anti-tumor and anti-aging effects. It restores expression of the body’s self-repair and apoptosis-surveillance machinery.

Molecular targets: HDAC 1/2/3/8, Histone H3/H4 acetylation, p21 gene reactivation

Supplements acting on this mechanism (ranked by strength and evidence)

Sodium butyrate / tributyrin

★★★☆☆Mechanism evidence: grade C

In some experimental models, butyrate can inhibit HDAC and promote the differentiation of some regulatory T cells. The evidence for HDAC inhibition and Foxp3-related acetylation comes from animal and in-vitro studies. Whether standard oral products reach effective concentrations in target human tissues is still uncertain.

Sulforaphane

★★☆☆☆Mechanism evidence: grade B

Sulforaphane metabolites can inhibit HDAC in vitro. A small number of human studies found that HDAC activity in monocytes dropped briefly after eating broccoli sprouts. But the dose-response is unclear, as are the duration of the effect and its subtype selectivity.

Curcumin

★☆☆☆☆Mechanism evidence: grade D

In some cell models, curcumin can inhibit HDAC activity. The mechanistic evidence so far comes mainly from cell and mouse experiments. Human studies measured changes in HDAC-related gene expression, which is not the same as inhibited enzyme activity. Direct inhibition in the body after usual oral dosing has not been confirmed.

Open in the interactive app ›